STRIBILD
STRIBILD
Approved
DIN Number
02397137
Drug Class
Human
Market Date
Dec 20, 2012
Company
HC
gilead sciences canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02397137
AIG Number0453433001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR09 EMTRICITABINE, TENOFOVIR DISOPROXIL, ELVITEGRAVIR AND COBICISTAT
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification
ACTIVE INGREDIENTS (4)
COBICISTATActive
Strength: 150 MG
Monograph: COBICISTAT
ELVITEGRAVIRActive
Strength: 150 MG
Monograph: ELVITEGRAVIR
EMTRICITABINEActive
Strength: 200 MG
Monograph: EMTRICITABINE
TENOFOVIR DISOPROXIL FUMARATEActive
Strength: 300 MG
Monograph: TENOFOVIR DISOPROXIL FUMARATE